332 related articles for article (PubMed ID: 17442937)
1. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.
Nazareth MR; Broderick L; Simpson-Abelson MR; Kelleher RJ; Yokota SJ; Bankert RB
J Immunol; 2007 May; 178(9):5552-62. PubMed ID: 17442937
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors.
Barnas JL; Simpson-Abelson MR; Brooks SP; Kelleher RJ; Bankert RB
J Immunol; 2010 Sep; 185(5):2681-92. PubMed ID: 20686130
[TBL] [Abstract][Full Text] [Related]
3. Comment on "Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells".
Ghebeh H; Dermime S
J Immunol; 2007 Jul; 179(2):732; author reply 733. PubMed ID: 17617559
[No Abstract] [Full Text] [Related]
4. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice.
Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A
J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458
[TBL] [Abstract][Full Text] [Related]
6. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
[TBL] [Abstract][Full Text] [Related]
7. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
8. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
9. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
[TBL] [Abstract][Full Text] [Related]
10. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures.
Della Corte CM; Barra G; Ciaramella V; Di Liello R; Vicidomini G; Zappavigna S; Luce A; Abate M; Fiorelli A; Caraglia M; Santini M; Martinelli E; Troiani T; Ciardiello F; Morgillo F
J Exp Clin Cancer Res; 2019 Jun; 38(1):253. PubMed ID: 31196138
[TBL] [Abstract][Full Text] [Related]
12. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice.
Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF; Kelleher RJ; Shultz LD; Barcos M; Bankert RB
J Immunol; 2008 May; 180(10):7009-18. PubMed ID: 18453623
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation.
Yang W; Li H; Chen PW; Alizadeh H; He Y; Hogan RN; Niederkorn JY
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):273-80. PubMed ID: 18791172
[TBL] [Abstract][Full Text] [Related]
14. The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.
Briere D; Sudhakar N; Woods DM; Hallin J; Engstrom LD; Aranda R; Chiang H; Sodré AL; Olson P; Weber JS; Christensen JG
Cancer Immunol Immunother; 2018 Mar; 67(3):381-392. PubMed ID: 29124315
[TBL] [Abstract][Full Text] [Related]
15. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.
Jurado JO; Alvarez IB; Pasquinelli V; Martínez GJ; Quiroga MF; Abbate E; Musella RM; Chuluyan HE; García VE
J Immunol; 2008 Jul; 181(1):116-25. PubMed ID: 18566376
[TBL] [Abstract][Full Text] [Related]
16. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458
[TBL] [Abstract][Full Text] [Related]
17. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis.
Mazanet MM; Hughes CC
J Immunol; 2002 Oct; 169(7):3581-8. PubMed ID: 12244148
[TBL] [Abstract][Full Text] [Related]
18. [Effects of anti-PD-L1 monoclonal antibody and EGFR-TKI on the expression of PD-L1 and function of T lymphocytes in EGFR-mutated lung cancer cells].
She Y; Pan X; Xing YF; Zhou T; Zhang ZL; Shi MH; Chen YJ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):886-892. PubMed ID: 27998463
[No Abstract] [Full Text] [Related]
19. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
20. Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma.
Hess SD; Egilmez NK; Bailey N; Anderson TM; Mathiowitz E; Bernstein SH; Bankert RB
J Immunol; 2003 Jan; 170(1):400-12. PubMed ID: 12496425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
